ABIVAX Société Anonyme(NASDAQ:ABVX) 
ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in P...
Website: https://www.abivax.com/
Founded: 2013
IPO Price: $11.6 (Oct 20, 2023)
Sector: TECHNOLOGY
Industry: GENERAL
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 5.54
H 5.75
L 5.16
C 5.32
V 150,559
10EMA 5.32
20EMA 5.32
60EMA 5.32
120EMA 5.32
250EMA 5.32